Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands

European Child and Adolescent Psychiatry

Volumn 19, Issue 2, 2010, Pages 159-166

  Faber, Adrianne ^a   Kalverdijk, Luuk J ^b   De Jong Van Den Berg, Lolkje T W ^c   Hugtenburg, Jacqueline G ^d   Minderaa, Ruud B ^b   Tobi, Hilde ^e  

^a SIR Institute for Pharmacy Practice and Policy   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Attention deficit hyperactivity disorder; Co medication; Co morbidity; Multimodal treatment; Stimulants

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLONIDINE; DEXAMPHETAMINE; HYPNOTIC AGENT; MELATONIN; METHYLPHENIDATE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; CENTRAL STIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; CHILD CARE; CHILD PARENT RELATION; CHILDHOOD DISEASE; COMORBIDITY; CONDUCT DISORDER; CONTROLLED STUDY; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; OPPOSITIONAL DEFIANT DISORDER; PHARMACY; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; QUESTIONNAIRE; SCHOOL CHILD; ADOLESCENT; CLINICAL PRACTICE; DRUG UTILIZATION; NETHERLANDS; PARENT; STATISTICS;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMORBIDITY; CONDUCT DISORDER; DRUG UTILIZATION; FEMALE; HUMANS; MALE; NETHERLANDS; PARENTS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 77950358369     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-009-0075-y     Document Type: Article

References (33)

1. P Accardo TA Blondis 2001 What's all the fuss about Ritalin? J Pediatr 138 6 9 10.1067/mpd.2001.108205 1:STN:280:DC%2BD3M7ktVGmtA%3D%3D 11148505
2. American Academy of Child and Adolescent Psychiatry 1997 Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 36 85S 121S
3. American Academy of Pediatrics 2001 Clinical practice guideline: diagnosis an evaluation of the child with attention-deficit hyperactivity disorder Pediatrics 108 1033 1044 10.1542/peds.108.4.1033 (Pubitemid 32947681)
4. M Boles FL Lynch LL DeBar 2001 Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care J Child Adolesc Psychopharmacol 11 43 52 10.1089/104454601750143429 1:STN:280: DC%2BD3M3jtVGrtQ%3D%3D 11322744
5. JK Buitelaar RJ van der Gaag P Cohen-Kettenis, et al. 2001 A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities J Clin Psychiatry 62 239 248 1:CAS:528:DC%2BD3MXkt1CmsL4%3D 11379837
6. T Clark C Feehan C Tinline, et al. 1999 Autistic symptoms in children with attention deficit-hyperactivity disorder Eur Child Adolesc Psychiatry 8 50 55 10.1007/s007870050083 1:STN:280:DyaK1M3psVWlsw%3D%3D 10367741 (Pubitemid 29222751)
7. M Delbello S Grcevich 2004 Phenomenology and epidemiology of childhood psychiatric disorders that may necessitate treatment with atypical antipsychotics J Clin Psychiatry 65 Suppl 6 12 19 1:CAS:528:DC%2BD2cXks1Khu7k%3D 15104522
8. A Faber LTW van den Berg KA Netjes, et al. 2005 Recruitment of parents and physicians of stimulant-using children via community pharmacies is successful J Clin Epidemiol 58 1072 1073 10.1016/j.jclinepi.2005.03.007 16168354 (Pubitemid 41316451)
9. A Faber LJ Kalverdijk JG Hugtenburg, et al. 2006 Parents report on stimulant-treated youths in the Netherlands: initiation and follow-up care J Child Adolesc Psychopharmacol 16 432 440 10.1089/cap.2006.16.432 16958568 (Pubitemid 44681463)
10. C Gillberg IC Gillberg P Rasmussen, et al. 2004 Co-existing disorders in ADHD-implications for diagnosis and intervention Eur Child Adolesc Psychiatry 13 I80 I92 10.1007/s00787-004-1008-4 15322959 (Pubitemid 39165254)
11. S Goldstein AJ Schwebach 2004 The co-morbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: results of a retrospective chart review J Autism Dev Disord 34 329 339 10.1023/B:JADD. 0000029554.46570.68 15264500 (Pubitemid 38860213)
12. K Hoagwood KJ Kelleher M Feil, et al. 2000 Treatment services for children with ADHD: a national perspective J Am Acad Child Adolesc Psychiatry 39 198 206 10.1097/00004583-200002000-00020 1:STN:280:DC%2BD3c7jvVOrtA%3D%3D 10673831
13. PS Jensen SP Hinshaw HC Kraemer 2001 ADHD co-morbidity findings from the MTA study: Comparing co-morbid subgroups J Am Acad Child Adolesc Psychiatry 40 147 158 10.1097/00004583-200102000-00009 1:STN:280:DC%2BD3M7ktFCnsA%3D%3D 11211363
14. S Kutcher M Aman SJ Brooks, et al. 2004 International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive disorders (DBDs): Clinical implications and treatment practice suggestions Eur Neuropsychopharmacol 14 11 28 10.1016/S0924-977X(03)00045-2 1:CAS:528: DC%2BD3sXps1Gkur0%3D 14659983 (Pubitemid 37495027)
15. Leufkens HGM, Urquhart J (2000) Automated pharmacy record linkage in the Netherlands. In: Strom BL (ed) Pharmacoepidemiology, 3rd edn. Wiley, Chichester
16. EF Luteijn M Serra S Jackson, et al. 2000 How unspecified are disorders of children with a pervasive developmental disorder not otherwise specified? A study of social problems in children with PDD-NOS and ADHD Eur Child Adolesc Psychiatry 9 168 179 10.1007/s007870070040 1:STN:280:DC%2BD3MzpsVyguw%3D%3D 11095039
17. A Martin T Van Hoof D Stubbe, et al. 2003 Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care Psychiatr Serv 54 72 77 10.1176/appi.ps.54.1.72 12509670 (Pubitemid 36043850)
18. Mash EJ, Barkley RA (2003) Child pathology. The Guilford Press, New York
19. AR Miller CE Lalonde KM McGrail, et al. 2001 Prescription of methylphenidate to children and youth, 1990-1996 Can Med Assoc J 165 1489 1494 1:STN:280:DC%2BD38%2Fjs1eitw%3D%3D
20. M Olfson SC Marcus MM Weissman, et al. 2002 National trends in the use of psychotropic medications by children J Am Acad Child Adolesc Psychiatry 41 514 521 10.1097/00004583-200205000-00008 12014783 (Pubitemid 38338129)
21. M Radigan P Lannon P Roohan, et al. 2005 Medication patterns for attention-deficit/hyperactivity disorder and co-morbid psychiatric conditions in a low-income population J Child Adolesc Psychopharmacol 15 44 56 10.1089/cap.2005.15.44 15741785 (Pubitemid 40365913)
22. R Reid P Hakendorf B Prosser 2002 Use of psychostimulant medication for ADHD in South Australia J Am Acad Child Adolesc Psychiatry 41 906 913 10.1097/00004583-200208000-00008 12162626 (Pubitemid 38338069)
23. Research Units on Pediatric Psychopharmacology Autism Network 2005 Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity Arch Gen Psychiatry 63 1266 1274 10.1001/archpsyc.62.11.1266 (Pubitemid 41586926)
24. Research Units on Pediatric Psychopharmacology Autism Network 2001 Risperidone in children with autism and serious behavioral problems N Engl J Med 347 5 314 321
25. LM Robison DA Sclar TL Skaer, et al. 2004 Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder:1995-99 Int Clin Psychopharmacol 19 17 22 10.1097/00004850-200401000-00003 15101565 (Pubitemid 38114619)
26. DJ Safer 2000 Are stimulants overprescribed for youths with ADHD? Ann Clin Psychiatry 12 55 62 1:STN:280:DC%2BD3c3ls1OgtQ%3D%3D 10798827
27. MG Sawyer JM Rey BW Graetz, et al. 2002 Use of medication by young people with attention-deficit/hyperactivity disorder Med J Australia 177 21 25 12088474
28. E Schirm H Tobi JM Zito, et al. 2001 Psychotropic medication in children: a study from the Netherlands Pediatrics 108 e25 10.1542/peds.108.2.e25 1:STN:280:DC%2BD3MvjvVWrsg%3D%3D 11483835
29. E Taylor M Döpfner J Sergeant, et al. 2004 European clinical guidelines for hyperkinetic disorder-first upgrade Eur Child Adolesc Psychiatry 13 7 30 10.1007/s00787-004-1002-x (Pubitemid 39172160)
30. The MTA Cooperative Group 1999 A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder Arch Gen Psychiatry 56 1073 1086 10.1001/archpsyc.56.12.1073
31. Y Yoshida T Uchiyama 2004 The clinical necessity for assessing attention deficit/hyperactivity disorder (AD/HD) symptoms in children with high-functioning pervasive developmental disorder (PDD) Eur Child Adolesc Psychiatry 13 307 314 10.1007/s00787-004-0391-1 15490278 (Pubitemid 39390322)
32. JM Zito DJ Safer S DosReis, et al. 1999 Psychotropic medication patterns for youths with attention deficit hyperactivity disorder Arch Pediatr Adolesc Med 153 1257 1263 1:STN:280:DC%2BD3c%2Flslamuw%3D%3D 10591302
33. JM Zito DJ Safer S DosReis, et al. 2000 Trends in the prescribing of psychotropic medications to preschoolers JAMA 283 1025 1030 10.1001/jama.283.8. 1025 1:STN:280:DC%2BD3c7mtVWgtw%3D%3D 10697062